<--- Back to Details
First PageDocument Content
Medicine / Allergy / Immunoglobulin E / T helper cell / Fc receptor / Interleukin / Mast cell / Immunology / Atopy / Biology / Anatomy / Immune system
Date: 2013-04-01 14:25:24
Medicine
Allergy
Immunoglobulin E
T helper cell
Fc receptor
Interleukin
Mast cell
Immunology
Atopy
Biology
Anatomy
Immune system

I. Basic Immunology A. Immune Mechanisms 1. Innate versus adaptive immunity LANDMARK PUBLICATION: Krieg AM, Yi A, Matson S et al CpG motifs in bacterial DNA trigger B-cell activation.

Add to Reading List

Source URL: www.aaaai.org

Download Document from Source Website

File Size: 153,59 KB

Share Document on Facebook

Similar Documents

Curing Allergic Diseases S-TARget therapeutics GmbH Mooslackengasse 17, 1190 Vienna, Austria. Phone:+, +, +Confidential

Curing Allergic Diseases S-TARget therapeutics GmbH Mooslackengasse 17, 1190 Vienna, Austria. Phone:+, +, +Confidential

DocID: 1rgTJ - View Document

SuppreMol_Crawford Release ENG_Mar 4, 2015

SuppreMol_Crawford Release ENG_Mar 4, 2015

DocID: 1qGKf - View Document

Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor &alpha; antibody, in a phase I study of patients with mild asthma

Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor &alpha; antibody, in a phase I study of patients with mild asthma

DocID: 1qDqa - View Document

KASCHE & PARTNER AG INTELLECTUAL PROPERTY Dr. André Kasche  Dr. Oliver Horlacher

KASCHE & PARTNER AG INTELLECTUAL PROPERTY Dr. André Kasche Dr. Oliver Horlacher

DocID: 1qxAK - View Document

Validation of Peptide Immunotherapy as a New Approach in the Treatment of Allergic Rhinoconjunctivitis: The Clinical Benefits of Treatment with Amb a 1 Derived T cell Epitopes

Validation of Peptide Immunotherapy as a New Approach in the Treatment of Allergic Rhinoconjunctivitis: The Clinical Benefits of Treatment with Amb a 1 Derived T cell Epitopes

DocID: 1qs00 - View Document